Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

This Is Your Brain on Opioids: Tips on Understanding Addiction and Recovery
  • USA - English


News provided by

MCPR, LLC

Aug 24, 2016, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Russell Surasky
Dr. Russell Surasky

Understanding how opioids change the brain helps us understand why it is so challenging for an addict to simply stop using drugs.

Post this

Great Neck, NY, (PRWEB) August 24, 2016 -- Despite the broad reach of opioid addiction into every segment of the American population and its heartbreaking effects on individuals and families, most people know and understand little about how opioids wreak havoc on the brain and why the cycle of abuse is so hard to break. In 2014, almost 2.5 million Americans suffered from substance abuse disorders involving opioids, about 80% of them involving misuse and abuse of prescription pain relievers such as hydrocodone, oxycodone, morphine, codeine, and fentanyl, and about 20% involving the illegal drug, heroin.1 “Understanding how opioids change the brain helps us understand why it is so challenging for an addict to simply stop using drugs,” says neurologist and addiction medicine specialist Dr. Russell Surasky with Surasky Neurological Center for Addiction. “Addiction is not a moral failing. It is a complex, chronic disease with a lifelong risk of relapse. Fortunately, as we have developed an understanding of how opioids affect the brain, we have seen the introduction of treatments that can reverse the neurological damage and support a permanent recovery.”    

Dr. Surasky offers the following tips to help people understand more about opioids and what they do to the brain:

What are opioids?
The term “opioid” is generally used to refer to both drugs derived from the opium poppy, such as morphine, codeine, and heroin, and synthetic drugs that produce similar narcotic effects such as Oxycodone and Hydrocodone more popularly known as Percocet and Vicodin. Opiate receptors are found in the brain and spinal cord. They significantly reduce the sensation of pain but also play an enormous role in the way we feel mentally and emotionally. They cause an overall feeling of “well-being”. They significantly reduce symptoms such as depression and anxiety. Opiates also cause negative symptoms including drowsiness, nausea and constipation. The human body naturally produces its own substances (“endogenous opioids”) that act in similar ways to modulate pain and also regulate life-sustaining functions such as the need for food, water, and sex. Endogenous opioids trigger the brain's reward center to produce feelings of pleasure when these vital needs are satisfied. “Opioid drugs stimulate the reward system just as endogenous opioids do,” says Dr. Surasky. “They produce a euphoric effect and over time rewire the brain to pursue that effect as it does a basic life need, making the individual as powerless to resist the impulse to take more drugs as he or she is to resist the need for food and water.”

How do opioids act on the brain?
Opioids attach to proteins called “opioid receptors” located on nerve cells in the brain and stimulate them to flood the reward system with dopamine and other substances that reduce pain and produce pleasurable feelings. Opioid drugs act on the same receptors as our own endogenous opioids but their chemical composition may produce a more intense effect. “Opioids prescribed for pain are powerful aids in relieving suffering,” says Dr. Surasky, “but they have great potential for misuse and become dangerous and addictive when taken to excess or for non-medical purposes.” Drugs overstimulate the reward system, producing not just a calming, pleasurable feeling but the euphoria that characterizes opioid abuse. When the drug wears off it detaches from the receptors and the brain signals the need for another dose.

How can opioid addiction be successfully treated?
After as little as a few weeks of use, opiates 'hijack' the brain to the point that it needs the drug for survival and the compulsion to continue taking the drug becomes overwhelming. “Withdrawal and counseling aren't enough,” says Dr. Surasky. “Unless the neurological changes to the brain can be reversed, those cravings may persist for a lifetime. One of the newer and most effective treatments is Vivitrol®, an extended-release medication that is injected once a month and immediately stops cravings.” Vivitrol is a safe medication that that helps the brain to heal from the changes that have occurred during the drug use. Vivitrol itself is not an opioid, is not addictive and does not cause dependence. A patient who has been treated with Vivitrol and then takes opiates anyway will not feel high. Dr. Surasky states “people who are treated with Vivitrol but then take opiate drugs do not get sick or high, absolutely nothing will occur. Patients quickly learn that they might as well throw their money in the garbage before spending it on these drugs.” Treatment is individualized for each patient to ensure that the psychological and behavioral aspects of the disease have been adequately addressed and the individual has developed the life skills needed to remain drug free.

“Drug addiction destroys lives and families,” says Dr. Surasky. “Medication-assisted treatment can heal the brain by undoing the neurological damage opioids have inflicted and along with ongoing behavioral therapy offers patients a lifeline and the hope of a permanent recovery.”

1 Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. http://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf

Vivitrol® is a registered trademark of Alkermes, Inc.

Russell Surasky, FAAN, ABAM, with Surasky Neurological Center for Addiction, is board certified in both neurology and addiction medicine, and is one of the few physicians with this combination of credentials. His primary focus in practice is addiction medicine. Utilizing unique medication protocols individualized to each patient, he provides specialized treatment for opiate, benzodiazepine, and alcohol addiction. http://www.drsurasky.com

Melissa Chefec, MCPR, LLC, http://www.mcprpublicrelations.com, +1 (203) 968-6625, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.